Key Insights

Highlights

Success Rate

73% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

17.1%

6 terminated out of 35 trials

Success Rate

72.7%

-13.8% vs benchmark

Late-Stage Pipeline

29%

10 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed with results

Key Signals

5 with results73% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (6)
P 1 (7)
P 2 (8)
P 3 (3)
P 4 (7)

Trial Status

Completed16
Unknown8
Terminated6
Withdrawn3
Recruiting2

Trial Success Rate

72.7%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT04225611Phase 1RecruitingPrimary

Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema

NCT07002372Not ApplicableRecruiting

Effect of Video Viewing on Intravitreal Injection Experience

NCT05832996Phase 4Completed

Cool vs Room-temperature Artificial Tears

NCT05158699Phase 3Terminated

Effectiveness of Periocular Drug Injection in CATaract Surgery

NCT00406172Phase 3WithdrawnPrimary

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

NCT05615805Not ApplicableCompleted

The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections

NCT05474950Phase 1Unknown

Minocycline Treatment for Cystoid Macular Edema

NCT04527523TerminatedPrimary

Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only

NCT05069675UnknownPrimary

Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment

NCT05337332Phase 2Unknown

Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases

NCT00790803Not ApplicableCompleted

Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema

NCT04856670UnknownPrimary

Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS

NCT04234438Not ApplicableCompleted

Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser

NCT01471054Phase 2Terminated

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

NCT03465124Not ApplicableUnknown

Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery

NCT02598869Phase 4Withdrawn

Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema

NCT02392364Phase 4CompletedPrimary

Variable Interval Versus Set Interval Aflibercept for DME

NCT03025945Not ApplicableCompletedPrimary

Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo

NCT02294656Phase 1CompletedPrimary

Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide

NCT02486484Phase 2Unknown

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

Scroll to load more

Research Network

Activity Timeline